Duke-Margolis Works to Ensure Safety of Drug Labels Center makes recommendations to FDA to minimize unintended consequences Changes to drug safety labeling by the Food and Drug Administration (FDA) provide patients and...
Margolis Center Study: The Missing Steps That Could Lower Costs and Improve Care for Seriously Ill People
Why Do Accountable Care Organizations Leave the Medicare Shared Savings Program? Bonuses and penalties for cost-reduction seem to be a key factor In new research published Monday in Health Affairs, authors from the Duke-Margolis Center for...
Duke’s ‘Embassy’ in Washington The Duke in DC office provides a welcome resource for Duke community members with work to do in the nation’s capital When Deondra Rose spent nearly a month in Washington D.C. doing research for her upcoming book,...
News Tip: FDA Approval of First Postpartum Depression Drug Could Be a ‘Game-Changer’ The FDA has approved the first drug for postpartum depression, a therapy that increases the naturally occurring chemical allopregnanolone in the brain Quote: Dr. Chris Marx “Postpartum...
Study: Regulatory Policy Changes Needed to Bring AI Into Clinical Decision Making A new white paper from the Duke-Margolis Center for Health Policy outlines the policy needs for...
Duke to Hold Its First Health Conference in India Duke University will host its first health conference in India on Dec. 13-14 that will focus on...
